Pamela Kunz, MD
Associate Professor of Internal Medicine (Medical Oncology); Director, Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice Chief, Diversity, Equity, and Inclusion, Medical Oncology
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Kunz joins Yale from Stanford University School of Medicine where she was Director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship. Beyond her record of accomplishment in GI Oncology, Dr. Kunz is an international leader in the clinical care of patients with neuroendocrine tumors (NETs) and is advancing the field through clinical trials and translational science that are defining the next generation of therapies for patients with this rare diagnosis.
Education & Training
- Oncology FellowStanford University (2008)
- Chief ResidentStanford University (2005)
- Internal Medicine ResidentStanford University (2004)
- MDDartmouth Medical School (2001)
- BADartmouth College, Biology (1994)
Departments & Organizations
- Center for Gastrointestinal Cancers
- Developmental Therapeutics
- Internal Medicine
- Medical Oncology
- Office of DEI in Medicine
- Status of Women in Medicine Committee (SWIM)
- Subset Medical Oncology Faculty
- WHRY Pilot Project Program Investigators
- Yale Cancer Center
- Yale Medicine
- YCC Diversity, Equity, and Inclusion